Tovetumab
Tovetumab is a monoclonal antibody designed for the treatment of cancer. This drug was developed by Merck & Co.
History[edit]
Tovetumab was one of many experimental drugs developed in the early 21st century to combat various forms of cancer. It was developed by Merck & Co, a multinational pharmaceutical company based in the United States.
Mechanism of Action[edit]
As a monoclonal antibody, Tovetumab works by targeting and attaching to specific proteins on the surface of cancer cells. This allows the immune system to better recognize and attack these cells.
Clinical Trials[edit]
Tovetumab has undergone various clinical trials to test its safety and efficacy. These trials are crucial steps in the drug development process, and they help determine whether a drug should be approved for use.
Side Effects[edit]
Like all drugs, Tovetumab can cause side effects. These can vary widely from patient to patient, and they can include both physical and psychological symptoms.
See Also[edit]
References[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
